Large-scale testing (Phase 3)Study completedNCT03478787What this trial is testingRisankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis AbbVie 327
Testing effectiveness (Phase 2)Study completedNCT05896527What this trial is testingEvaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company 229
Post-approval studies (Phase 4)Study completedNCT05891964What this trial is testingOutcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital.Who this might be right forPlaque Psoriasis Jinnah Postgraduate Medical Centre 50
Post-approval studies (Phase 4)Study completedNCT03020199What this trial is testingStudy of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Novartis Pharmaceuticals 196
Early research (Phase 1)Looking for participantsNCT06888193What this trial is testingAssess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)Who this might be right forModerate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more UCB Biopharma SRL 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT07148414What this trial is testingSPY072 in Rheumatic DiseaseWho this might be right forRheumatoid ArthritisPsoriatic ArthritisAxial Spondyloarthritis+5 more Spyre Therapeutics, Inc. 285
Testing effectiveness (Phase 2)Study completedNCT05283135What this trial is testingHigh Dose Risankizumab for PsoriasisWho this might be right forPsoriasis Oregon Medical Research Center 20
Not applicableStudy completedNCT05388916What this trial is testingA Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in ChinaWho this might be right forModerate to Severe Chronic Plaque Psoriasis Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT00669916What this trial is testingA Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque PsoriasisWho this might be right forPlaque Psoriasis Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT01001468What this trial is testingStudy to Assess VB-201 in Patients With PsoriasisWho this might be right forActive Plaque Psoriasis Vascular Biogenics Ltd. operating as VBL Therapeutics 185
Large-scale testing (Phase 3)Study completedNCT03598790What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forChronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis UCB Biopharma SRL 1,353
Not applicableStudy completedNCT02271971What this trial is testingEffect of Vitamin D Supplementation on Metabolic Parameters of Patients With PsoriasisWho this might be right forPsoriasisMetabolic SyndromeVitamin D Deficiency Pontificia Universidad Catolica de Chile 39
Post-approval studies (Phase 4)Study completedNCT02749370What this trial is testingStudy to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With ApremilastWho this might be right forPlaque Psoriasis Amgen 80
Large-scale testing (Phase 3)Active Not RecruitingNCT03997786What this trial is testingTildrakizumab in Pediatric Subjects With Chronic Plaque PsoriasisWho this might be right forModerate-to-severe Chronic Plaque Psoriasis Sun Pharmaceutical Industries Limited 135
Large-scale testing (Phase 3)Not Yet RecruitingNCT07432854What this trial is testingA Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis Dermavon Holdings Limited 540
Testing effectiveness (Phase 2)Study completedNCT04102241What this trial is testingEfficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Tianjin Hemay Pharmaceutical Co., Ltd 216
Not applicableUnknownNCT01753245What this trial is testingAnalysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice.Who this might be right forPsoriasis VulgarisMetabolic Syndrome Juan Ruano 300
Large-scale testing (Phase 3)Study completedNCT04175613What this trial is testingA Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Amgen 160
Large-scale testing (Phase 3)Not Yet RecruitingNCT06643260What this trial is testingStudy in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and EfficacyWho this might be right forPlaque Psoriasis Can-Fite BioPharma 705
Large-scale testing (Phase 3)Ended earlyNCT01708590What this trial is testingEfficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis SubjectsWho this might be right forPsoriasis Bausch Health Americas, Inc. 661